PJO-HNS… A Steady Progress

Steady progress on Parkinson's disease.

Treatment of Parkinson's disease is expected to lead to $3.56 billion in global sales in 2022. Manufacturers are reformulating medications in addition to creating new ones.

Inclusion body myositis pathogenesis: Steady progress.

Inclusion body myositis (IBM) is a slowly progressive skeletal muscle disease for which no effective pharmacological therapy is available. Since its initial pathological description 50 years ago, substantial progress has been made in our clinical understanding of IBM. We now have extensive understanding of its demographics, pattern of muscle involvement, and diagnostic criteria, and large amoun...

Travellers' diarrhoea: slow but steady progress.

Gene therapy for cystic fibrosis: steady progress, should do well.

Slow but steady progress towards understanding peri-procedural myocardial infarction.

Despite over two decades of research, the clinical significance and optimal management of peri-procedural myocardial infarction (PMI) remains a matter of considerable controversy. The topic is important because percutaneous coronary intervention (PCI) is the dominant method for revascularization, with over a million patients around the world receiving the therapy each year. The large body of da...